ArticleEuropean heart journal. Cardiovascular Imaging2025
Value of cardiovascular magnetic resonance-derived quantitative myocardial blood flow assessment in the setting of chronic coronary occlusion.
Article in European heart journal. Cardiovascular Imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Commented on by
Authors and funding
10 authors.
Funding
Abstract
aimsFor many years, visual assessment has been the mainstay of detecting obstructive coronary artery disease (CAD) by stress perfusion cardiovascular magnetic resonance (S-CMR). Recently, fully automated quantitative assessment of myocardial blood flow (MBF) has been introduced. The value of MBF quantification in patients with coronary chronic total occlusion (CTO) is unknown. In this study, we sought to investigate the diagnostic performance of CMR-derived fully automated quantitative MBF assessment in patients with CTO. METHODS AND
resultsConsecutive patients who underwent S-CMR, as well as coronary angiography at our institution between February 2023 and November 2024 were included. S-CMR perfusion imaging was evaluated visually and quantitatively. Stenosis severity was assessed angiographically and >70% was considered severe stenosis. One hundred thirty patients [age 66.7 (59.7-75.2) years, 79.2% male] were included in this analysis. Patients were grouped according to CAD severity (non-obstructed coronary arteries <70%, n = 57; severe stenosis >70%, n = 37; CTO, n = 36). Stress MBF (SMBF) and myocardial perfusion reserve (MPR) were significantly reduced in patients with CTO compared with those with severe stenosis and non-obstructed coronary arteries, respectively. Segmental SMBF <1.02 mL/g/min differentiated CTO from severe stenosis with a good predictive power [area under the curve: 0.792 (95% confidence interval: 0.678-0.887)]. Moreover, integrated visual and quantitative perfusion assessment provided high sensitivity in detecting additional severe stenosis in CTO patients (91.3%).
conclusionAddition of fully automated MBF quantification to clinical routine visual S-CMR reading facilitates non-invasive differentiation between CTO and severe stenosis and provides higher sensitivity regarding true ischaemic burden in patients with CTO and multi-vessel disease, thereby aiding clinical decision-making.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.